HONG KONG (Reuters/IFR) – Chinese biotech Ascletis Pharma Inc raised $400 million (£303 million) after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong K…
( read original story …)
The HongKong News
HONG KONG (Reuters/IFR) – Chinese biotech Ascletis Pharma Inc raised $400 million (£303 million) after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong K…
( read original story …)